AccuStem Sciences, Inc.
ACUT
$0.98
$0.09410.61%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.36% | -13.38% | -17.97% | 47.17% | -114.07% |
| Total Depreciation and Amortization | -66.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -61.54% | 1,243.09% | 35.25% | -23.63% | -8.54% |
| Change in Net Operating Assets | -55.67% | 31.60% | 66.97% | -79.94% | 487.11% |
| Cash from Operations | -72,650.00% | 100.18% | -4.16% | 11.88% | 19.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -13.08% | -4.73% | -8.23% |
| Total Debt Repaid | 21.30% | -37.29% | -8.76% | 61.04% | 8.09% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,092.28% | -115.50% | -15.01% | 9.19% | -8.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 197.81% | -255.56% | -124.52% | 403.31% | 75.56% |